News
Major trial launched to explore GLP-1 benefit in dementia
A $100m trial has been launched to see if lifestyle changes coupled with GLP-1 agonists or similar incretins can reduce the risk of dementia.
News
GSK to file Jemperli for rectal cancer after phase 3 readout
GSK's pivotal AZUR-1 trial of Jemperli monotherapy to delay or eliminate surgery in pre-operative rectal cancer has delivered a positive result.
News
Pay offer rejected as ICR researchers continue strike action
Researchers at the UK Institute of Cancer Research have held historic strikes over pay, claiming they are missing meals and struggling to cover bills.
News
Sleep apnoea drug firm Apnimed files for IPO
Apnimed has joined the IPO queue on the Nasdaq, hoping to raise additional funding for its late-stage oral therapy for obstructive sleep apnoea.
News
Non-profit DNDi preps phase 3 trials for dengue antibody
Non-profit DNDi has licensed a dengue therapy from India's SII, paving the way for a phase 3 trial in Malaysia, Thailand, and Brazil.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
